# Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771

> **NCT05640531** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 36 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** WCK 771 IV Infusion
- **OTHER:** Placebo IV Infusion

## Key facts

- **NCT ID:** NCT05640531
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-01
- **Primary completion:** 2012-02-07
- **Final completion:** 2012-06-27
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05640531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05640531, "Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05640531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*